Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature

被引：1
|
作者：
Cobo, Francesc [1 ]
De Celis, Guillern
Pereira, Arturo
Latorre, Xavier
Pujadas, Jaume
Albiol, Santiago
机构：
[1] Hosp Ntra Sra, Oncohematol Unit, De Meritxell, Escaldes Engord, Andorra
[2] Hosp Ntra Sra, Dept Internal Med, De Meritxell, Escaldes Engord, Andorra
[3] Hosp Clin Barcelona, Immunohematol Unit, Dept Hemotherapy & Hemostasis, Barcelona, Spain
来源：
ANTI-CANCER DRUGS | 2007年 / 18卷 / 08期
关键词：
chemotherapy; colorectal cancer; immune cytopenia;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We report a 59-year-old woman diagnosed with metastasic colorectal cancer who developed immune hemolytic anemia during FOLFOX chemotherapy (oxaliplatin/leucovorin/5-fluorouracil). lmmunohematologic studies demonstrated that immune hemolysis was oxaliplatin-mediated. On the basis of this case and in a review of the literature in which 13 cases of previously reported oxaliplatin-induced immune cytopenia have been identified, we suggest some clinical clues regarding the use of oxaliplatin in cancer patients.
引用
收藏
页码：973 / 976
页数：4
相关论文
共 50 条
  • [31] Oxaliplatin-induced thrombotic microangiopathy: a case report
    Rhea Saad
    Audra Hannun
    Sally Temraz
    Antoine Finianos
    Rony M. Zeenny
    Journal of Medical Case Reports, 16
  • [32] Ceftriaxone-induced immune hemolytic anemia: a case report
    Wang, Li
    Jiang, Yongxian
    Li, Gen
    Zhang, Liaoyun
    Qin, Bo
    Li, Aiyan
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [33] CeftriaxoneDrug-induced immune hemolytic anemia: case report
    Reactions Weekly, 2021, 1856 (1) : 129 - 129
  • [34] Hemolytic Anemia and Metastatic Carcinoma: Case Report and Literature Review
    Pendse, Avani A.
    Edgerly, Claire H.
    Fedoriw, Yuri
    LABMEDICINE, 2014, 45 (02): : 132 - 135
  • [35] Danazol in Refractory Autoimmune Hemolytic Anemia or Immune Thrombocytopenia: A Case Series Report and Literature Review
    Huang, Hsu-En
    Lin, Ko-Ming
    Lin, Jing-Chi
    Lin, Yu-Ting
    He, Hsiao-Ru
    Wang, Yu-Wei
    Yu, Shan-Fu
    Chen, Jia-Feng
    Cheng, Tien-Tsai
    PHARMACEUTICALS, 2022, 15 (11)
  • [36] A Fatal Case Report of Ceftriaxone-induced Hemolytic Anemia and Literature Review in Pediatrics
    Lu, Jinmiao
    Li, Qin
    Li, Xiaoxia
    Li, Zhiping
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2018, 14 (06) : 896 - 900
  • [37] Oxaliplatin Induced Hemolytic Anemia
    Harputluoglu, Hakan
    Dizdar, Oemer
    Aksoy, Sercan
    Barista, Ibrahim
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2009, 19 (02): : 127 - 128
  • [38] A case of oxaliplatin-induced immune-mediated thrombocytopenia
    Suh, Seong Eun
    Jang, Moon Ju
    Chong, So Young
    Aster, Richard H.
    Curtis, Brian R.
    Oh, Doyeun
    BLOOD RESEARCH, 2014, 49 (01) : 61 - 64
  • [39] Oxaliplatin-induced immune pancytopenia
    Taleghani, BM
    Fontana, S
    Meyer, O
    Ahrens, N
    Novak, U
    Borner, MM
    Salama, A
    TRANSFUSION, 2005, 45 (05) : 704 - 708
  • [40] Oxaliplatin-Induced Thrombocytopenia: A Case Report and Review of Pathophysiology of Various Speculative Mechanisms
    Ghazanfar, Haider
    Nawaz, Iqra
    Ali, Nisha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
12345